A Large Language Model Pipeline for Breast Cancer Oncology

• URL: http://arxiv.org/abs/2406.06455v2
• Date: Thu, 13 Jun 2024 18:48:17 GMT
• Title: A Large Language Model Pipeline for Breast Cancer Oncology
• Abstract summary: State-of-the-art OpenAI models were fine-tuned on a clinical dataset and clinical guidelines text corpus for two important cancer treatment factors. A high accuracy (0.85+) was achieved in the classification of adjuvant radiation therapy and chemotherapy for breast cancer patients.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Large language models (LLMs) have demonstrated potential in the innovation of many disciplines. However, how they can best be developed for oncology remains underdeveloped. State-of-the-art OpenAI models were fine-tuned on a clinical dataset and clinical guidelines text corpus for two important cancer treatment factors, adjuvant radiation therapy and chemotherapy, using a novel Langchain prompt engineering pipeline. A high accuracy (0.85+) was achieved in the classification of adjuvant radiation therapy and chemotherapy for breast cancer patients. Furthermore, a confidence interval was formed from observational data on the quality of treatment from human oncologists to estimate the proportion of scenarios in which the model must outperform the original oncologist in its treatment prediction to be a better solution overall as 8.2% to 13.3%. Due to indeterminacy in the outcomes of cancer treatment decisions, future investigation, potentially a clinical trial, would be required to determine if this threshold was met by the models. Nevertheless, with 85% of U.S. cancer patients receiving treatment at local community facilities, these kinds of models could play an important part in expanding access to quality care with outcomes that lie, at minimum, close to a human oncologist.

Related papers

• Causal multi-modal AI for personalized chemosensitivity prediction [6.027095223294588]
  Current guidelines rely on recurrence scores as a proxy for treatment benefit.<n>We present a causal multi-modal AI model that predicts personalized chemosensitivity using routinely collected pathology and clinical information.
  arXiv  Detail & Related papers  (2026-09-11T22:11:06Z)
• TRAPS: Therapeutic Response Analysis via Pathway-informed Stratification [1.2117611469472138]
  We present the first unified benchmark for pathway-guided therapy response modeling.<n>We evaluate BINN, GraphPath, and PATH across five cancer cohorts from The Cancer Genome Atlas.
  arXiv  Detail & Related papers  (2026-06-05T04:59:09Z)
• Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment [56.62016795093786]
  Cerebra is an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis.<n>It supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete.<n>Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation.
  arXiv  Detail & Related papers  (2026-03-23T05:46:45Z)
• Leveraging Large Language Models and Survival Analysis for Early Prediction of Chemotherapy Outcomes [0.0]
  Chemotherapy for cancer treatment is costly and accompanied by severe side effects.<n> Predictive models for chemotherapy outcomes using real-world data face challenges.<n>This study addresses these challenges by employing Large Language Models (LLMs) and ontology-based techniques.
  arXiv  Detail & Related papers  (2026-03-12T06:25:12Z)
• A Disease-Centric Vision-Language Foundation Model for Precision Oncology in Kidney Cancer [54.58205672910646]
  RenalCLIP is a visual-language foundation model for characterization, diagnosis and prognosis of renal mass.<n>It achieved better performance and superior generalizability across 10 core tasks spanning the full clinical workflow of kidney cancer.
  arXiv  Detail & Related papers  (2025-08-22T17:48:19Z)
• Deep Learning Enabled Segmentation, Classification and Risk Assessment of Cervical Cancer [0.0]
  Cervical cancer, the fourth leading cause of cancer in women globally, requires early detection through Pap smear tests.<n>In this study, we performed a focused analysis by segmenting the cellular boundaries and drawing bounding boxes to isolate the cancer cells.<n>A novel Deep Learning architecture, the Multi-Resolution Fusion Deep Convolutional Network", was proposed to effectively handle images with varying resolutions and aspect ratios.
  arXiv  Detail & Related papers  (2025-05-21T13:25:27Z)
• Cancer-Answer: Empowering Cancer Care with Advanced Large Language Models [0.0]
  Gastrointestinal (GI) tract cancers account for a substantial portion of the global cancer burden. Cancer-related queries are crucial for timely diagnosis, treatment, and patient education. We leverage large language models (LLMs) such as GPT-3.5 Turbo to generate accurate, contextually relevant responses to cancer-related queries.
  arXiv  Detail & Related papers  (2024-11-11T12:54:22Z)
• AI-assisted prostate cancer detection and localisation on biparametric MR by classifying radiologist-positives [5.75804178993065]
  We propose to develop deep learning models that improve the overall cancer diagnostic accuracy. We develop a single voxel-level classification model, with a simple percentage threshold to determine positive cases. Based on the presented experiments from two clinical data sets, we show that the proposed strategy can improve the diagnostic accuracy.
  arXiv  Detail & Related papers  (2024-10-30T14:59:57Z)
• Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-based Tool [0.40205899806543505]
  Deep-BCR-Auto is a deep learning-based computational pathology approach that predicts breast cancer recurrence risk. Our methodology was validated on two independent cohorts. Deep-BCR-Auto demonstrated robust performance in stratifying patients into low- and high-recurrence risk categories.
  arXiv  Detail & Related papers  (2024-09-23T19:22:06Z)
• Towards Non-invasive and Personalized Management of Breast Cancer Patients from Multiparametric MRI via A Large Mixture-of-Modality-Experts Model [19.252851972152957]
  We report a mixture-of-modality-experts model (MOME) that integrates multiparametric MRI information within a unified structure. MOME demonstrated accurate and robust identification of breast cancer. It could reduce the need for biopsies in BI-RADS 4 patients with a ratio of 7.3%, classify triple-negative breast cancer with an AUROC of 0.709, and predict pathological complete response to neoadjuvant chemotherapy with an AUROC of 0.694.
  arXiv  Detail & Related papers  (2024-08-08T05:04:13Z)
• Enhancing Clinically Significant Prostate Cancer Prediction in T2-weighted Images through Transfer Learning from Breast Cancer [71.91773485443125]
  Transfer learning is a technique that leverages acquired features from a domain with richer data to enhance the performance of a domain with limited data. In this paper, we investigate the improvement of clinically significant prostate cancer prediction in T2-weighted images through transfer learning from breast cancer.
  arXiv  Detail & Related papers  (2024-05-13T15:57:27Z)
• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Prediction of Breast Cancer Recurrence Risk Using a Multi-Model Approach Integrating Whole Slide Imaging and Clinicopathologic Features [0.6679306163028237]
  The aim of this study was to develop a multi-model approach integrating the analysis of whole slide images and clinicopathologic data to predict associated breast cancer recurrence risks. The proposed novel methodology uses convolutional neural networks for feature extraction and vision transformers for contextual aggregation.
  arXiv  Detail & Related papers  (2024-01-28T23:33:56Z)
• Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
  The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023. The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy. In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
  arXiv  Detail & Related papers  (2023-04-12T15:08:34Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• Exploiting segmentation labels and representation learning to forecast therapy response of PDAC patients [60.78505216352878]
  We propose a hybrid deep neural network pipeline to predict tumour response to initial chemotherapy. We leverage a combination of representation transfer from segmentation to classification, as well as localisation and representation learning. Our approach yields a remarkably data-efficient method able to predict treatment response with a ROC-AUC of 63.7% using only 477 datasets in total.
  arXiv  Detail & Related papers  (2022-11-08T11:50:31Z)
• Automatic Generation of Interpretable Lung Cancer Scoring Models from Chest X-Ray Images [9.525711971667679]
  Lung cancer is the leading cause of cancer death worldwide. Deep learning techniques are effective at automatically diagnosing lung cancer. These techniques have yet to be clinically approved and adopted by the medical community.
  arXiv  Detail & Related papers  (2020-12-10T04:11:59Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.